Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device

Area of Science:

• Biomedical Engineering
• Oncology
• Nanotechnology

Background:

• Pancreatic cancer treatment remains challenging, necessitating novel therapeutic strategies.
• Combining chemotherapy with sonodynamic therapy shows promise for pancreatic cancer.
• Targeted delivery of therapeutics using oxygen-loaded magnetic microbubbles is under investigation.

Purpose of the Study:

• To evaluate a magnetic-acoustic device (MAD) for co-aligned magnetic and ultrasound fields.
• To assess the MAD's efficacy in concentrating and activating microbubbles at the target site.
• To determine the therapeutic potential of MAD-guided microbubble delivery for pancreatic cancer.

Main Methods:

• In vitro experiments using tissue phantoms to measure therapeutic payload deposition.
• In vivo studies involving xenograft pancreatic cancer (BxPC-3) tumors in a murine model.
• Comparison of treatment outcomes between the MAD, separate magnetic/ultrasound devices, and microbubbles alone.

Main Results:

• The MAD achieved a 1.4-fold increase in therapeutic payload deposition in vitro (p < .01).
• In vivo, MAD-treated tumors showed a 9% smaller mean volume after 8 days.
• Tumors treated with separate devices or microbubbles alone increased by 45% and 112%, respectively.

Conclusions:

• The magnetic-acoustic device effectively addresses the co-alignment challenge for targeted microbubble delivery.
• MAD-guided sonodynamic therapy demonstrates significant tumor volume reduction in preclinical pancreatic cancer models.
• This approach holds potential as an effective neoadjuvant therapy for pancreatic cancer.